SCHEMBL566673

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL16508607	0.90	CA1 (0.34)	F10CA1CA2GAA
	SCHEMBL472683	0.89	CA1 (0.34)	CA1CA2GAAMAPTSMN1; SMN2
	SCHEMBL472295	0.88	CA1 (0.35)	F10CA1CA2GAA
	SCHEMBL472694	0.88	NPSR1 (0.33)	CA1CA2GAAMAPT
	SCHEMBL472769	0.86	CA1 (0.34)	F10CA1CA2GAA
	SCHEMBL472622	0.86	CA1 (0.33)	F10CA1CA2GAAMAPT
	SCHEMBL472733	0.86	ALDH1A1 (0.35)	CA1CA2GAAMAPTSMN1; SMN2
	SCHEMBL10132745	0.86	HTT (0.35)	F10CA1CA2GAAMAPT
	SCHEMBL565285	0.86	CA1 (0.34)	F10CA1CA2GAAMAPT
	SCHEMBL472706	0.86	CA1 (0.32)	F10CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.